Therefore, measuring exoRNA and ctDNA in BWF specimens may greatly improve the detection of EGFR mutations, even at an early stage of lung cancer; however, further studies are needed to evaluate this possibility. The gene discussed is EGFR; the disease is lung carcinoma.